Hereditary regulatory enzymopathies are considered, molecular-genetic mechanism of which involved a mutation of a structural gene in the locus, coding the much less than regular much greater than amino acid sequence in the allosteric site of regulatory enzyme or the site of the enzyme polypeptide chain, which is responsible for allosteric conformational transition. Dissimilar manifestations of regulatory and classical enzymopathies are discussed. Estimation of kinetic patterns might be very useful in diagnosis of regulatory enzymopathies as shown during study of some molecular pathologies, which occurred, for example, due to molecular pathology of phosphofructokinase and phosphoribosyl pyrophosphate synthetase. Impairment of allosteric regulation of L-threonine-L-serine dehydratase is considered as a model of regulatory enzymopathy, found in spontaneous hepatomas of highly carcinogenous CBA mice strain. Treatment of regulatory enzymopathies is considered depending on the effect of well known chemotherapeutic drugs (mainly, acetyl salicylic acid) on allosteric functions of regulatory enzymes acetyl-CoA-carboxylase and fructose-1,6-bisphosphatase from animal liver tissue.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Therapeutics through glycobiology: an approach for targeted elimination of malaria.
Biologia (Bratisl)
January 2023
Department of Biotechnology, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal, 576104 Karnataka India.
The emergence of drug resistance in jeopardises worldwide malaria eradication efforts necessitating novel therapeutic approaches and therefore the identification of key metabolic pathways of parasite and human host for drug development garners importance. Enzymopathies like glucose-6-phosphate-dehydrogenase (G6PD) and pyruvate kinase (PK) deficiencies have been shown to protect against the severe consequences of malaria. Glycome profiles and the regulatory mechanisms involving the microRNAs or transcription factors' expression related to the histo-blood group glycogenes may add up to resolve the underlying pathogenesis.
View Article and Find Full Text PDFNovel pathogenic variant c.2714C>A (p. Thr905Lys) in the gene causing severe haemolytic anaemia with developmental delay in an Indian family.
J Clin Pathol
October 2021
Hematogenetics, National Institute of Immunohaematology, Mumbai, Maharashtra, India
Hexokinase (EC 2.7.1.
View Article and Find Full Text PDFBiochemical Analysis of Two Single Mutants that Give Rise to a Polymorphic G6PD A-Double Mutant.
Int J Mol Sci
October 2017
Laboratorio de Bioquímica Genética, Instituto Nacional de Pediatría, Secretaría de Salud, Mexico City 04530, Mexico.
Glucose-6-phosphate dehydrogenase (G6PD) is a key regulatory enzyme that plays a crucial role in the regulation of cellular energy and redox balance. Mutations in the gene encoding G6PD cause the most common enzymopathy that drives hereditary nonspherocytic hemolytic anemia. To gain insights into the effects of mutations in G6PD enzyme efficiency, we have investigated the biochemical, kinetic, and structural changes of three clinical G6PD variants, the single mutations G6PD A+ (Asn126AspD) and G6PD Nefza (Leu323Pro), and the double mutant G6PD A- (Asn126Asp + Leu323Pro).
View Article and Find Full Text PDFPathophysiology of brain dysfunction in hyperammonemic syndromes: The many faces of glutamine.
Mol Genet Metab
June 2015
Dept. of Medicine, University of Montreal and Neuroscience Research Unit, St-Luc Hospital (CHUM), Montreal, Qc, Canada.
Ineffective hepatic clearance of excess ammonia in the form of urea, as occurs in urea cycle enzymopathies (UCDs) and in liver failure, leads to increases in circulating and tissue concentrations of glutamine and a positive correlation between brain glutamine and the severity of neurological symptoms. Studies using 1H/13C Nuclear Magnetic Resonance (NMR) spectroscopy reveal increased de novo synthesis of glutamine in the brain in acute liver failure (ALF) but increases of synthesis rates per se do not correlate with either the severity of encephalopathy or brain edema. Skeletal muscle becomes primarily responsible for removal of excess ammonia in liver failure and in UCDs, an adaptation that results from a post-translational induction of the glutamine synthetase (GS) gene.
View Article and Find Full Text PDFAnalysis of enzymopathies in the human red blood cells by constraint-based stoichiometric modeling approaches.
Comput Biol Chem
October 2006
Department of Chemical Engineering, Boğaziçi University, 34342 Bebek-Istanbul, Turkey.
The human red blood cell (RBC) metabolism is investigated by calculating steady state fluxes using constraint-based stoichiometric modeling approaches. For the normal RBC metabolism, flux balance analysis (FBA) is performed via optimization of various alternative objective functions, and the maximization of production of ATP and NADPH is found to be the primary objective of the RBC metabolism. FBA and two novel approaches, minimization of metabolic adjustment (MOMA) and regulatory on-off minimization (ROOM), which can describe the behavior of the metabolic networks in case of enzymopathies, are applied to observe the relative changes in the flux distribution of the deficient network.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!